A foretaste for pediatric glioblastoma therapy: targeting the NF-kB pathway with DHMEQ.

María Sol BrassescoGabriela Molinari RobertoLara Elis DelsinGabriel Carlos BaldisseraMariana MedeirosKazuo UmezawaLuiz Gonzaga Tone

Published in: Child's nervous system : ChNS : official journal of the International Society for Pediatric Neurosurgery (2023)

Taken together, our results strengthen the potential usefulness of NF-kB inhibition in future therapeutic strategies to overcome this incurable disease.

Keyphrases

signaling pathway
lps induced
pi k akt
nuclear factor
oxidative stress
current status
inflammatory response
cancer therapy
human health
toll like receptor
young adults
mesenchymal stem cells
climate change
chemotherapy induced